Year All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2012 2011 Sep 1, 2026 Ardelyx to Participate in Upcoming Investor Conferences Aug 6, 2026 Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update Jul 23, 2026 Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026 May 19, 2026 Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 May 7, 2026 Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings Apr 30, 2026 Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update Apr 27, 2026 Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings Apr 23, 2026 Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 Apr 20, 2026 Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer Apr 16, 2026 Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026